Literature DB >> 23600501

Immune-tolerizing procedure for preparation of monoclonal antibodies against glycoprotein E of Pseudorabies virus.

Shun Lu1, Min Xiang, Hanbing Dan, Bin Wu, Qishuang Gao, Haijun Huang, Qigai He, Huanchun Chen.   

Abstract

The glycoprotein E (gE) of pseudorabies virus (PRV) is known to be an important marker protein in the control and eradication of Aujeszky's disease. In this study, BALB/c mice were immunized with gE-deleted PRV as tolerogen and with wild-type PRV as immunogen. The spleen cells from the immunized mice were then fused with the myeloma cell line Sp2/0. Two hybridoma cell lines that could stably secrete the monoclonal antibody (MAb) against gE were achieved by using indirect ELISA screening and subcloning three times; they were named 1D2 and 2B2. Indirect immunofluorescence assay (IFA) revealed that the MAbs were specifically against gE of PRV. MAbs 1D2 and 2B2 were subgroup IgG1. The MAbs obtained in this study provide useful tools for the development of differential diagnostic methods for PRV.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23600501      PMCID: PMC4014296          DOI: 10.1089/mab.2012.0068

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN: 2167-9436


  12 in total

1.  Aujeszky's disease eradication in New Zealand.

Authors:  S C MacDiarmid
Journal:  Aust Vet J       Date:  2000-07       Impact factor: 1.281

2.  Eradication of Aujeszky's disease in Germany.

Authors:  T Müller; H-J Bätza; H Schlüter; F J Conraths; T C Mettenleiter
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2003-06

3.  Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus.

Authors:  J T van Oirschot; F Daus; T G Kimman; D van Zaane
Journal:  Am J Vet Res       Date:  1991-11       Impact factor: 1.156

Review 4.  Determination of the effectiveness of Pseudorabies marker vaccines in experiments and field trials.

Authors:  Annemarie Bouma
Journal:  Biologicals       Date:  2005-11-07       Impact factor: 1.856

Review 5.  Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.

Authors:  Lisa E Pomeranz; Ashley E Reynolds; Christoph J Hengartner
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

6.  Aujeszky's disease virus eradication campaign successfully heading for last stage in The Netherlands.

Authors:  A R Elbers; J Braamskamp; L J Dekkers; R Voets; T Duinhof; W A Hunneman; J A Stegeman
Journal:  Vet Q       Date:  2000-04       Impact factor: 3.320

7.  Subtractive immunization: a tool for the generation of discriminatory antibodies to proteins of similar sequence.

Authors:  Heidi Major Sleister; A Gururaj Rao
Journal:  J Immunol Methods       Date:  2002-03-01       Impact factor: 2.303

Review 8.  Aujeszky's disease virus: opportunities and challenges.

Authors:  F A Zuckermann
Journal:  Vet Res       Date:  2000 Jan-Feb       Impact factor: 3.683

9.  Development of a monoclonal antibody-based broad-specificity ELISA for fluoroquinolone antibiotics in foods and molecular modeling studies of cross-reactive compounds.

Authors:  Zhanhui Wang; Yan Zhu; Shuangyang Ding; Fangyang He; Ross C Beier; Jiancheng Li; Haiyang Jiang; Caiwei Feng; Yuping Wan; Suxia Zhang; Zhenpeng Kai; Xinling Yang; Jianzhong Shen
Journal:  Anal Chem       Date:  2007-05-19       Impact factor: 6.986

10.  Application of an immune-tolerizing procedure to generate monoclonal antibodies specific to an alternate protein isoform of bovine growth hormone.

Authors:  R A Salata; I J Malhotra; R K Hampson; D F Ayers; C S Tomich; F M Rottman
Journal:  Anal Biochem       Date:  1992-11-15       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.